December 19, 2022 – ARLINGTON, VA. – The Bio-Process Systems Alliance (BPSA), the international association of the single-use bio-processing industry, is pleased to announce the election of the following BPSA Executive Board members and Directors-at-Large for 2023/2024. 

Mark Petrich, PhD, Vice President, Process Development and Validation, Krystal Biotech, Inc. has been elected BPSA Chair, 2023-2024; Joseph St. Laurent, Head of Industry Relations & Regulatory Expert, Solvias, Inc. has been elected First Vice Chair; Todd Kapp, Global Commercial Development Director-Life Sciences, Entegris, Inc., has been elected Second Vice Chair, and Hernan Parma of Renolit Healthcare and Danielle Arcuri of Qosina, Inc. have been elected to the Board as Directors-at-Large. 

“I want to congratulate Mark on being elected BPSA Chair” said BPSA outgoing Chair, Jeff Carter, PhD, of Cytiva, whose term as Chair is ending on December 31, 2022. “The BPSA Board represents the entire value chain of the single-use industry, inclusive of resin producers, component manufacturers, system integrators, global OEM suppliers, analytical laboratories and end-users, and we are pleased to have an end-user/pharmaceutical manufacturer in the role of BPSA Chair for the first time.”

“I also want to congratulate Joseph St. Laurent of Solvias, Inc. on being elected First Vice Chair, Todd Kapp of  Entegris, Inc., on being elected Second Vice Chair, and Hernan Parma of Renolit Healthcare and Danielle Arcuri of Qosina, Inc. on being elected to the Board,” Carter continued. “We thank each of our volunteer leaders for their desire to serve on the BPSA Board, and we look forward to working with them in continuing to advance the adoption and use of single-use manufacturing processes and systems in vaccine and biopharmaceutical production. We also want to thank Robert Sassa of W. L. Gore and Scott Herskovitz of Qosina, whose terms as Directors-at-Large are ending this year.” 

Mark has been active with BPSA for include over ten years, including Board and Executive Board service, first with Merck & Co., Inc., and now at Krystal Biotech, Inc. He has served as Chair of the BPSA End-User Committee, co-authored several BPSA white papers, and helped successfully launch the BPSA Sustainability Committee. 

“It’s an honor to be elected to serve as BPSA Chair for 2023-2024. I want to thank Jeff for his service to the board and his leadership as Chair,” said Petrich. “Under Jeff’s leadership, the Alliance continued to grow and to serve the needs of its members and the biopharmaceutical industry. Many of the changes and challenges presented by the COVID-19 pandemic were addressed by single-use technologies and the efforts of BPSA member companies. As demand for single-use bioprocessing systems increased, Jeff’s leadership was key to putting BPSA in a position to help our members and the patients we all serve. I look forward to working with all the BPSA members and our volunteer leaders, as well as our partners and allied organizations, to continue to advance BPSA and the single-use bioprocessing industry.”

The roster of 2023/2024 Board Members is as follows:

BPSA Executive Board Officers: 

• Chair: Mark Petrich, Krystal Biotech, Inc.
• First Vice-Chair: Joseph St. Laurent, Solvias, Inc. 
• Second Vice Chair: Todd Kapp, Entegris, Inc.
• Treasurer:  VACANT
• Secretary: Todd Andrews, CPC
• Scientific Advisory Board Chair, Technical Committee Chair: Kirsten Strahlendorf, Sanofi Pasteur

At-Large Directors (newly elected/re-elected) through 2024:

• Danielle Arcuri, Qosina Corporation
• Ralph Daumke, PendoTECH
• Patrick Evrard, Pall Corporation
• Charlotte Masy, GSK Vaccines
• Ravi Narayanan, Nordson Medical
• Hernan Parma, Renolit Healthcare
• Mark Sitcoske, High Purity New England
• Elisabeth Vachette, Sartorius Stedim Biotech

At-Large Directors continuing through 2023:

• Monica Cardona, MilliporeSigma
• Brian Chung, Solvay, Inc.
• Dan Rosen, Thermo Fisher Scientific

About BPSA

The Bio-Process Systems Alliance (BPSA), an affiliated organization of the Society of Chemical Manufacturers & Affiliates (SOCMA), was formed in 2005 as an industry-led association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. BPSA facilitates education, sharing of best practices, development of consensus guides and business-to-business networking opportunities among its member company employees. For more information, visit www.bpsalliance.org, or contact Executive Director Chris Clark at cclark@socma.org.

ARLINGTON, Va., Oct. 4, 2022 /PRNewswire/ — The Bio-Process Systems Alliance (BPSA), the international association of the single-use bio-processing industry, announced the election of a Secretary to its Executive Board and three at-large members to its Board of Directors for 2022-2023.

Todd Andrews, Director of Application & Business Development, Colder Products Company (CPC) will serve as Secretary, and new at-large members are:

• Monica Cardona, Global Senior Program Manager, Single Use & Integrated Systems, MilliporeSigma
• Brian Chung, Senior Key Account Manager – Specialty Polymers, Solvay
• Dan Rosen, Vice President & General Manager – Single Use Technologies Flexible Solutions, Thermo Fisher Scientific

“The Alliance is pleased to have Todd Andrews join the Executive Board as Secretary,” said BPSA Chairman Jeff Carter of Cytiva. “He is very active in BPSA and has served on the Board of Directors for a number of years. I also welcome Monica Cardona, Dan Rosen and Brian Chung to the Board. I look forward to working with each of them to advance the use of single-use technologies in biopharmaceutical and vaccine production and advance the mission and objectives of BPSA.”

Todd has been involved in the single-use biopharmaceutical industry for more 15 years with a focus on single-use connection technology and has been an active BPSA member for almost 10 years. Todd has a bachelor’s degree in Plastics Engineering from University of Massachusetts, Lowell, and a master’s in business administration from the University of Saint Thomas.

Monica has been MilliporeSigma since 2019, and her previous roles include senior-level marketing and product management in the single-use and integrated systems sector. Monica served as Senior Marketing Manager-Single Use & Integrated Systems, and prior to her roles at MilliporeSigma, Monica was Global Product Manager Personal Protection Equipment with Cantel Medical Company and was Global Product Manager at Pall Life Sciences. Monica holds a bachelor’s degree in biology from Hofstra University and a master’s degree in biology from Adelphi University.

Prior to his role as Senior Account Manager at Solvay, Brian served as a Digital Sales Account Manager for Specialty Polymers and as Product Manager-Sulfation, Phosphation and Concentrates at Solvay. Brian holds a Bachelor of Science/M.S.E. in Chemical & Biomolecular Engineering from Johns Hopkins University.

Dan has been with Thermo Fisher Scientific for five years, and previously served as VP-GM for the company. Rosen has previous experience and expertise in investment banking and strategy consulting. Dan holds a bachelor’s degree from Brown University and a master’s in business administration from the Tuck School at Dartmouth College.

The complete roster of BPSA Board Members can be found here: https://bpsalliance.org/about/board-of-directors/

About BPSA

The Bio-Process Systems Alliance (BPSA), an affiliated organization of the Society of Chemical Manufacturers & Affiliates (SOCMA), was formed in 2005 as an industry-led association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. Learn more at www.bpsalliance.org

Arlington, VA – The Bio-Process Systems Alliance (BPSA) announced the publication of its latest guide, the 19-page Single-Use Technologies Enable Manufacturers to Meet Pivotal Challenges of Viral Vector Manufacturing.

Recent years have seen dramatic breakthroughs in cell and gene therapies. Cell and gene therapy (CGT) is a science that is ushering in a new era in medicine. One of the main focuses of this technique is the optimization and delivery of Viral Vector vehicles that are mostly nanostructures, or viruses.

This new BPSA guide discusses present and future challenges in gene therapy manufacturing and how single-use technologies (SUTs) can improve the manufacturing process, including upstream production and downstream purification; product and operator safety; processing in closed systems and how single-use technology enables cost-effective manufacturing. The white paper also sheds light on some of the future opportunities for SUTs in gene therapy production.

“SUT’s are essential to viral vector manufacturing success, and this guide provides insights that will enable biopharmaceutical manufacturers to make smart choices about where single use can improve outcomes and speed of therapies to market,” said Brendan Lucey, Global Director of Cross Business Unit Market Strategy, Entegris, and Chair of the BPSA Cell and Gene Therapy Committee.

Viral Vector manufacturing is still in an early stage of development, and this emerging segment in biopharmaceutical manufacturing is benefiting from the recent surge in production of vaccines and monoclonal antibodies in response to the Covid-19 pandemic. While challenges still exist in the scale-up of Viral Vector manufacturing components, SUTs have been almost fully integrated in the process at commercial scale, and the SUT supply base is actively responding to these needs.

“The Viral Vector white paper is the culmination of an 18-month process, and I want to thank the BPSA Cell and Gene Therapy Committee, and all of the authors, contributors and editors for their hard work on this guide,” said Chris Clark, BPSA Executive Director. “BPSA and the single-use supply chain continues to work collaboratively to ensure a robust, safe, and reliable manufacturing base for cell and gene therapy production.”

Contact BPSA Executive Director, Chris Clark, to learn more, or visit the BPSA website to download a copy.

About BPSA
The Bio-Process Systems Alliance (BPSA), an affiliate of SOCMA, was formed in 2005 as an industry-led international industry association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. www.bpsalliance.org.